Back to articles

Adventist Health Glendale Introduces New Lung Screening Program


GLENDALE, CA – Adventist Health Glendale is proud to introduce a new lung cancer screening program and technology designed to offer health care providers a faster pathway to lung cancer detection and treatment.

Like all cancers, the key to lung cancer survival is early detection. In 2011, the National Lung Screening Trial (NLST) showed that screening with low-dose computed tomography (CT) reduced lung cancer deaths among a population of heavy smokers by 20 percent, when compared to using chest X-rays as the diagnostic tool.1 

Adventist Health Glendale has long been at the forefront of offering programs and cutting-edge technology for early detection of a wide range of conditions. The adoption of DynaLync and DynaCAD Lung software from Invivo Corporation provides critical tools to aid with the identification, tracking, and management of relevant information to help the AHGL team reach a quick, definitive diagnosis.

Clayton Lau, director of imaging at Adventist Health Glendale explains, “Adventist Health Glendale is in a unique position to be able to offer not only the advanced imaging technology to make early lung cancer detection possible, but the data insights, collaboration and tools that are needed to deliver the quality and consistency required for health systems to succeed in new, evidence-based models of patient care.” 

Lung cancer is the leading cause of cancer death for both men and women worldwide, and nearly 160,000 Americans die of lung cancer each year.2 Of the top four deadliest cancers in the U.S. (lung, prostate, breast and colorectal), lung cancer is the only one not subject to routine screening. Adventist Health Glendale's introduction of a lung cancer screening program could not have come at a more opportune time.   

For more information about Adventist Health Glendale and our lung cancer screening program, please call (818) 409-8003 to speak with our program coordinator or click here.


1The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365:395-409.
2American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015